Q3 2024 Earnings Call Transcript November 7, 2024 MannKind Corporation beats earnings expectations. Reported EPS is $0.05, ...
MannKind Corp (NASDAQ:MNKD)的首席人事与工作场所官Stuart A. Tross最近出售了55,000股公司普通股。这笔交易发生于2024年11月6日,平均价格为每股7.34美元,总价值为403,700美元。此次出售后,Tross仍保留967,191股公司股份的所有权。这项交易是根据2024年5月31日制定的10b5-1规则计划进行的。 在其他近期新闻中,MannKind ...
Shares of MannKind Co. (NASDAQ:MNKD – Get Free Report) have received a consensus recommendation of “Buy” from the seven ...
MannKind Corporation (NASDAQ: MNKD) 公布了2024年第三季度强劲的财务业绩,收入同比增长37%,并取得重要的临床进展。公司首席执行官Michael Castagna强调了Tyvaso DPI合作项目的强劲表现以及Afrezza处方量的稳步上升。公司拥有2.68亿美元的现金储备,第三季度非GAAP营业收入为1500万美元,这使MannKind有能力推进其临床研发管 ...
In a report released on November 7, Faisal Khurshid from Leerink Partners reiterated a Buy rating on MannKind (MNKD – Research Report), ...
MannKind (NASDAQ: MNKD) Q3 2024 Earnings Call Nov 07, 2024, 4:30 p.m. ET ...
MannKind will host a conference call and presentation webcast to discuss these results today at 4:30 p.m. Eastern Time. The webcast will be accessible via a link on MannKind’s website. A replay will ...
These compelling results support advancing the development of nintedanib DPI for patients living with IPF, a chronic and progressive fibrotic lung disease with limited treatment options,” said Michael ...
Q3 2024 Earnings Conference Call November 7, 2024 4:30 PM ETCompany ParticipantsMichael Castagna - CEOChris Prentiss ...
MannKind completes phase 1 trial of nintedanib DPI for pulmonary fibrotic diseases: Danbury, Connecticut Tuesday, November 5, 2024, 16:00 Hrs [IST] MannKind Corporation, a company ...
Waters new software delivers lab-centric business intelligence and enables confident audit-readiness: Our Bureau, Bengaluru Tuesday, November 12, 2024, 09:00 Hrs [IST] Waters Corp ...
MannKind Corporation (Nasdaq: MNKD), announced today that its third quarter 2024 financial results will be released after market ...